A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example.

<h4>Background</h4>Data on absolute risks of outcomes and patterns of drug use in cost-effectiveness analyses are often based on randomised clinical trials (RCTs). The objective of this study was to evaluate the external validity of published cost-effectiveness studies by comparing the d...

Full description

Saved in:
Bibliographic Details
Main Authors: Tjeerd-Pieter van Staa, Hubert G Leufkens, Bill Zhang, Liam Smeeth
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-12-01
Series:PLoS Medicine
Online Access:https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1000194&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!